Bureau Veritas has experience providing bioanalytical support and characterizing active pharmaceutical ingredients (API) in platinum-based therapeutics such as cisplatin, carboplatin and oxaliplatin. Our laboratory utilizes ICP-MS instrumentation to deliver sensitive and specific analysis. We handle drug compounds containing precious metals, rare earth elements, bismuth and transition metals.
Bureau Veritas has established validated methods for metallo-drug assays using ICP-MS at the low to sub ng/mL levels in common matrices of clinical interest, including urine, plasma and plasma ultrafiltrate. Bureau Veritas also has many pre-validated “off-the-shelf” bioanalytical methods available for other oncology drugs such as azathioprine and 6-mercaptopurine.